Literature DB >> 23413100

Development of HPTLC method for the estimation of ondansetron hydrochloride in bulk drug and sublingual tablets.

Ali Mujtaba1, Kanchan Kohli, J Ali, Sanjula Baboota.   

Abstract

A new, simple, rapid, accurate and precise high performance thin layer chromatography (HPTLC) method has been developed for the estimation of ondansetron hydrochloride in bulk and sublingual tablets. The mobile phase composition was chloroform : ethyl acetate : methanol : ammonia (9:5:4:0.1 v/v). Spectrodensitometric analysis of ondansetron was carried out at 254 nm and a symmetrical, well-resolved, well-defined peak was obtained at mean retardation factor (R(f) ) 0.52 ± 0.02. The calibration plot was linear in the range 200-1200 ng/spot and showed good linear relationship with coefficient of regression, R(2) = 0.9952 with respect to peak area. The method was validated according to the guidelines of the International Conference on Harmonization (ICH Q2(R1). The limit of detection and quantitation were 14.83 and 44.92 ng per spot, respectively. The recovery study was carried out by standard addition method and the percentage recovery was found to be 99.34 ± 1.08. Therefore it was concluded that the proposed developed HPTLC method can be applied for identification and quantitative determination of ondansetron in bulk drug and dosage forms.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23413100     DOI: 10.1002/dta.311

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  2 in total

1.  Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers.

Authors:  Yubing Zhu; Qian Zhang; Jianjun Zou; Meng Wan; Zheng Zhao; Junrong Zhu
Journal:  Drug Des Devel Ther       Date:  2015-08-12       Impact factor: 4.162

2.  Experimentally designed electrochemical sensor for therapeutic drug monitoring of Ondansetron co-administered with chemotherapeutic drugs.

Authors:  Mona A Abdel Rahman; Shimaa A Atty; Sally S El-Mosallamy; Mohamed R Elghobashy; Hala E Zaazaa; Ahmed S Saad
Journal:  BMC Chem       Date:  2022-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.